Analysts Set Arteris, Inc. (NASDAQ:AIP) Target Price at $17.50

Shares of Arteris, Inc. (NASDAQ:AIP) have been assigned an average recommendation of “Hold” from the five ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $17.50.

Several analysts recently commented on AIP shares. TD Cowen reiterated a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Jefferies Financial Group raised shares of Arteris to a “hold” rating in a research note on Tuesday, October 28th. Rosenblatt Securities reissued a “buy” rating and set a $20.00 target price on shares of Arteris in a research note on Monday, December 15th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st.

Arteris Trading Up 0.1%

NASDAQ AIP opened at $15.10 on Friday. The business’s 50-day moving average price is $16.32 and its two-hundred day moving average price is $13.22. Arteris has a 12 month low of $5.46 and a 12 month high of $19.85. The firm has a market capitalization of $659.57 million, a PE ratio of -18.19 and a beta of 1.47.

Key Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: NXP Semiconductors expanded its deployment of Arteris system IP (FlexNoC, Ncore, CodaCache) and integration tools across AI-enabled SoC, NPU and MCU designs — a clear commercial validation that can drive revenue growth and visibility in edge AI markets. Arteris Technology Deployed More Broadly by NXP
• Positive Sentiment: Institutional buying and analyst coverage remain constructive: multiple funds added AIP in recent quarters and Rosenblatt has a Buy rating (recent median price target ~$18.25), supporting upside vs. current levels.
• Neutral Sentiment: Q4 2025 earnings preview published — upcoming results could move the stock, but the preview itself contains no surprise guidance. Monitor the actual earnings release for revenue/visibility vs. AI-related design wins. What to Expect from Arteris Inc (AIP) Q4 2025 Earnings
• Neutral Sentiment: Short-interest reporting in the recent feeds is inconsistent (entries showing 0 shares or NaN alongside earlier data showing ~1.13M shares shorted as of Jan 30). Data appears noisy — treat short‑interest signals cautiously until exchanges/registrars reconcile the figures.
• Negative Sentiment: Insiders sold stock this week: CEO K. Charles Janac sold 47,244 shares on Feb 9 (~$15.21 avg) and 2,756 shares on Feb 10 (~$15.03 avg); major shareholder Bayview Legacy, LLC reported the same sales. The activity adds to a pattern of frequent insider sales reported over recent months and could weigh on sentiment. SEC filing: Janac insider sales

Insider Buying and Selling

In other Arteris news, VP Paul L. Alpern sold 5,000 shares of Arteris stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $15.48, for a total value of $77,400.00. Following the completion of the sale, the vice president directly owned 57,650 shares in the company, valued at approximately $892,422. The trade was a 7.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 2,756 shares of the business’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $15.03, for a total value of $41,422.68. Following the completion of the sale, the insider directly owned 9,349,071 shares of the company’s stock, valued at $140,516,537.13. The trade was a 0.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 689,072 shares of company stock valued at $11,525,611 over the last 90 days. Company insiders own 29.10% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of AIP. Deutsche Bank AG increased its position in shares of Arteris by 7.7% during the fourth quarter. Deutsche Bank AG now owns 21,159 shares of the company’s stock valued at $328,000 after acquiring an additional 1,504 shares during the last quarter. Cerity Partners LLC purchased a new position in Arteris in the fourth quarter valued at about $233,000. Franklin Resources Inc. grew its position in shares of Arteris by 6.2% during the 4th quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock valued at $27,017,000 after acquiring an additional 101,646 shares during the period. State of Wyoming purchased a new stake in shares of Arteris during the 4th quarter worth approximately $180,000. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Arteris by 144.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock worth $15,696,000 after purchasing an additional 598,840 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.